The splanchnic reservoir: an oasis for blood volume in heart failure with preserved ejection fraction?

Ravi B. Patel; Sanjiv J. Shah

doi:10.1002/ejhf.2268

The splanchnic reservoir: an oasis for blood volume in heart failure with preserved ejection fraction?

Ravi B. Patel^*, Sanjiv J. Shah

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Editorial › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1144-1146
Number of pages	3
Journal	European Journal of Heart Failure
Volume	23
Issue number	7
DOIs	https://doi.org/10.1002/ejhf.2268
State	Published - Jul 2021

Funding

: R.B.P. has no disclosures. S.J.S. has received research grants from Actelion, AstraZeneca, Corvia, Novartis, and Pfizer; and has received consulting fees from Abbott, Actelion, AstraZeneca, Amgen, Aria CV, Axon Therapies, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol‐Myers Squibb, Cardiora, CVRx, Cytokinetics, Edwards Lifesciences, Eidos, Eisai, Imara, Impulse Dynamics, Ionis, Ironwood, Lilly, Merck, MyoKardia, Novartis, Novo Nordisk, Pfizer, Prothena, Regeneron, Sanofi, Shifamed, Tenax, Tenaya, and United Therapeutics. Conflict of interest Dr. Patel is supported by grant KL2TR001424 from the National Center for Advancing Translational Sciences.

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/ejhf.2268

Cite this

@article{ff7fa651bc2148d3a7942063e44a17d4,

title = "The splanchnic reservoir: an oasis for blood volume in heart failure with preserved ejection fraction?",

author = "Patel, {Ravi B.} and Shah, {Sanjiv J.}",

note = "Funding Information: : R.B.P. has no disclosures. S.J.S. has received research grants from Actelion, AstraZeneca, Corvia, Novartis, and Pfizer; and has received consulting fees from Abbott, Actelion, AstraZeneca, Amgen, Aria CV, Axon Therapies, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol‐Myers Squibb, Cardiora, CVRx, Cytokinetics, Edwards Lifesciences, Eidos, Eisai, Imara, Impulse Dynamics, Ionis, Ironwood, Lilly, Merck, MyoKardia, Novartis, Novo Nordisk, Pfizer, Prothena, Regeneron, Sanofi, Shifamed, Tenax, Tenaya, and United Therapeutics. Conflict of interest Funding Information: Dr. Patel is supported by grant KL2TR001424 from the National Center for Advancing Translational Sciences. ",

year = "2021",

month = jul,

doi = "10.1002/ejhf.2268",

language = "English (US)",

volume = "23",

pages = "1144--1146",

journal = "European Journal of Heart Failure",

issn = "1388-9842",

publisher = "John Wiley and Sons Ltd",

number = "7",

}

TY - JOUR

T1 - The splanchnic reservoir

T2 - an oasis for blood volume in heart failure with preserved ejection fraction?

AU - Patel, Ravi B.

AU - Shah, Sanjiv J.

N1 - Funding Information: : R.B.P. has no disclosures. S.J.S. has received research grants from Actelion, AstraZeneca, Corvia, Novartis, and Pfizer; and has received consulting fees from Abbott, Actelion, AstraZeneca, Amgen, Aria CV, Axon Therapies, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol‐Myers Squibb, Cardiora, CVRx, Cytokinetics, Edwards Lifesciences, Eidos, Eisai, Imara, Impulse Dynamics, Ionis, Ironwood, Lilly, Merck, MyoKardia, Novartis, Novo Nordisk, Pfizer, Prothena, Regeneron, Sanofi, Shifamed, Tenax, Tenaya, and United Therapeutics. Conflict of interest Funding Information: Dr. Patel is supported by grant KL2TR001424 from the National Center for Advancing Translational Sciences.

PY - 2021/7

Y1 - 2021/7

UR - http://www.scopus.com/inward/record.url?scp=85110210402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85110210402&partnerID=8YFLogxK

U2 - 10.1002/ejhf.2268

DO - 10.1002/ejhf.2268

M3 - Editorial

C2 - 34118181

AN - SCOPUS:85110210402

SN - 1388-9842

VL - 23

SP - 1144

EP - 1146

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

IS - 7

ER -

The splanchnic reservoir: an oasis for blood volume in heart failure with preserved ejection fraction?

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this